Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors
Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors
Active, not recruiting · NCT03996265 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors | Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm | Active, not recruiting | Phase 3 | 2026-09-30 | NCT03996265 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| University of Rochester NCORP Research Base | 7 |
542 results · Page 1 of 22
Research sites
Swipe the table sideways for more columns.